Bill117th CongressFiled Jul 28, 2022Health
H.R. 8586
EFFECTIVE Act
Bill journey · stage 2 of 5
Under committee review
FiledFiled
CommitteeComm.
PassedFloor
Both ChambersBoth
Became LawLaw
What it doesSummary introduced in house (Jul 28, 2022)
Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act or the EFFECTIVE Act
This bill specifies that the Food and Drug Administration may deny an application for a new opioid analgesic drug upon a determination that the drug does not provide a significant advantage or clinical superiority compared to other drugs.
What just happenedJul 28, 2022
Referred to the House Committee on Energy and Commerce.
Who’s behind it
Rep. Trone, David J. [D-MD-6](D-MD)Sponsor
4 cosponsors3 D1 R
4cosponsors1committees3actions1related bills
- Introduced in HouseJul 28, 2022
- Jul 28, 2022IntroReferralH11100
Referred to the House Committee on Energy and Commerce.
Energy and Commerce Committee - Jul 28, 2022IntroReferralIntro-H
Introduced in House
- Jul 28, 2022IntroReferral1000
Introduced in House